Home › Stocks › NRSNW

NRSNW — NEUROSENSE THERAPEUTICS LTD

Reported value held$52.74K
Funds holding (latest)7
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)3
Institutional value$7.19K · 159.85K sh
New / Add / Cut / Exit0 / 0 / 1 / 0 · Updated 2026-11-16
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Reducing -2.9% (-4.80K sh)
Institutional value change Down -30.7%

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 3 SEC-registered investment managers reported holding NRSNW (NEUROSENSE THERAPEUTICS LTD) in their latest 13F filings, with a combined reported value of $7.19K across 159.85K shares. That is -2.9% by share count (-4.80K shares) versus the previous quarter, while reported value moved -30.7%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of NEUROSENSE THERAPEUTICS LTD (NRSNW) include Hudson Bay Capital Management LP, Citadel Advisors, Empery Asset Management, LP, ranked by reported 13F value among the 7 institutional holders on this page.

NRSNW is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 3 159.85K $7.19K -2.9%
Q2 2026 3 164.65K $10.37K -0.2%
Q1 2026 3 164.95K $32.82K +0.0%
Q4 2025 3 164.95K $56.70K -0.6%
Q3 2025 2 64.97K $24.60K -12.9%
Q2 2025 1 1.47K $932 -48.3%
Q1 2025 2 12.84K $2.63K -28.8%
Q4 2024 3 40.74K $14.97K -10.8%

Over the 8 quarters shown, institutional share counts increased 292% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (-48.3%).

Top Institutional Holders (Q3 2026) — 3 funds

FundSharesValuePortfolio WeightChange
Empery Asset Management, LP history 95.50K $4.30K 0.00% Reduce
Clear Street Group Inc. 63.19K $2.84K 0.00% Hold
UBS Group AG 1.16K $52 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 3 funds

FundSharesValuePortfolio WeightChange
Empery Asset Management, LP history 100.40K $6.33K 0.01% Hold
Clear Street Group Inc. 63.09K $3.97K 0.00% Hold
UBS Group AG 1.16K $73 0.00% Hold

Q1 2026 — 3 funds

FundSharesValuePortfolio WeightChange
Empery Asset Management, LP history 100.40K $20.08K 0.02% Hold
Clear Street Group Inc. 63.38K $12.68K 0.00% Hold
UBS Group AG 1.16K $64 0.00% Hold

Q4 2025 — 3 funds

FundSharesValuePortfolio WeightChange
Empery Asset Management, LP history 100.40K $36.15K 0.03% New
Clear Street Group Inc. 63.38K $20.26K 0.00% Hold
UBS Group AG 1.16K $291 0.00% Reduce

Q3 2025 — 2 funds

FundSharesValuePortfolio WeightChange
Clear Street Group Inc. 63.69K $24.20K 0.00% New
UBS Group AG 1.28K $397 0.00% Reduce

Q2 2025 — 1 funds

FundSharesValuePortfolio WeightChange
UBS Group AG 1.47K $932 0.00% Reduce

New Positions (Q3 2026)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 7 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q4 2021
Empery Asset Management, LP 95.50K 100.40K 100.40K 100.40K — — — — — — — — — — — — — —
Clear Street Group Inc. 63.19K 63.09K 63.38K 63.38K 63.69K — — — — — — — — — — — — —
UBS Group AG 1.16K 1.16K 1.16K 1.16K 1.28K 1.47K 2.84K 94 200 605 — — 3.80K — — 798 1.96K 4.49K
Hudson Bay Capital Management LP — — — — — — — — — — 86.75K 86.75K 86.75K — — — — —
Citadel Advisors — — — — — — — 22.71K 25.27K 29.46K 48.14K — 11.59K 37.93K 32.61K — — —
Warberg Asset Management LLC — — — — — — 10.00K 17.94K 20.20K 32.01K 41.41K 63.50K 76.11K — — — — —
Bank of America Corp — — — — — — — — — — — — 200 100 — — — —

Download holders (CSV)

FAQ

Which funds hold NRSNW?

As of 2026-Q3, 3 institutional funds reported holding NRSNW (NEUROSENSE THERAPEUTICS LTD) in SEC 13F filings, with a combined reported value of $7.19K.

How many shares of NRSNW do institutions own?

13F filers reported 159.85K shares of NRSNW, worth $7.19K in aggregate at the end of 2026-Q3.

Is institutional ownership of NRSNW rising or falling?

Share counts moved -2.9% versus the prior quarter — distribution.

Who are the top institutional holders of NRSNW?

The largest 13F holders are Hudson Bay Capital Management LP, Citadel Advisors, Empery Asset Management, LP, Clear Street Group Inc., Warberg Asset Management LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of NEUROSENSE THERAPEUTICS LTD?

The major shareholders of NEUROSENSE THERAPEUTICS LTD (NRSNW) by reported 13F value are Hudson Bay Capital Management LP, Citadel Advisors, Empery Asset Management, LP, Clear Street Group Inc., Warberg Asset Management LLC, among 7 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own NRSNW" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/NRSNW/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →